A California-based biotech company is finding early success on Tuesday after the company announced positive preliminary data of Vebreltinib in patients with non-CNS met fusion...

To read the full story on AllPennyStocks.com, click here.

Apollomics (NASDAQ:APLMW)
Historical Stock Chart
Von Okt 2024 bis Nov 2024 Click Here for more Apollomics Charts.
Apollomics (NASDAQ:APLMW)
Historical Stock Chart
Von Nov 2023 bis Nov 2024 Click Here for more Apollomics Charts.